Bated breath for Contrave, the new weight loss pill

Bated breath for Contrave, the new weight loss pill

446
0
SHARE

download (7)Some people are waiting with bated breath for the approval of the newest weight loss medication to be officially placed on the market. The diet drug Contrave’s approval by the Food and Drug Administration (FDA) is being eagerly awaited this week by many as another important addition in the fight against obesity.

Contrave was turned down by the FDA in 2011 when its maker Orexigen (a biopharmaceutical company that focuses on treatment of obesity) first submitted it, as additional requests were made for research on any possible cardiovascular risks. However, Contrave, or NB32, was resubmitted in December 2013 and interim results were encouraging from a 8900-patient Light Study. The monitoring committee also pointed to the diet drug being safe enough.

Sponsored Links

In clinical trials with Contrave, it was found that study participants lost on average five percent of their body weight, compared to other weight loss products such as Qsymia where people lose on average nine percent of their body weight and Belviq, with an average body weight loss of three percent. However, perhaps one of the reasons for the high anticipation for Contrave is that it is expected to be more easily available to the public than Qsymia and Belviq.

The latter two medications are considered controlled substances, and so health professional have to observe strict guidelines in prescribing them. On the other hand, Contrave is not expected to be approved by the FDA as a controlled substance, presenting less strict guidelines for prescriptions by doctors.

Contrave is a combination of two drugs – naltrexone (used in the treatment of alcoholism) and bupropion (an antidepressant which most people would recognize in the popular Wellbutrin.) When trial participants on buproprion had reported how much better they felt and looked, this provided a hint for researchers to explore the possibilities of its use in weight management.

Orexigen’s website explains that Contrave is believed to reduce appetite, help control cravings, increase metabolism, and improve control in overeating behaviors.

 

More News

New home sales ramped up in April, reaching the fastest sales pace since January 2008. According to the Commerce Department, new home sales climbed 16.6% in April to a seasonally adjusted rate of 619,000, up from 531,000 in March. The...
ZTE is slowly growing its presence in US. Last year, this Chinese giant released the brand new ZTE Axon series smartphones in the country and the new models turned out to be quite popular. Now, the company has...
Mortgage rates are remaining on Monday for the third day in a row after a short spike last week. On Monday, the best execution rate for a 30-year fixed-rate mortgage is 3.75%. Most major lenders are quoting 5-year ARMs...
OnePlus, the startup Chinese smartphone company has come a long way since it first unveiled its revolutionary OnePlus One flagship model. The manufacturer already has three smartphones in the market, all three selling even today. Now, the company is...
Mortgage rates are flat on Friday ahead of Memorial Day weekend and financial markets will be closed on Monday. Most lenders are leaving rates unchanged but a few are offering slightly lower interest rates. The most prevalent rate for...